Genetic determinants of platelet response to clopidogrel

Antiplatelet agents are the mainstay treatment in the prevention and management of atherothrombotic complications. However, a substantial interpatient variability in response to clopidogrel has been reported. Furthermore, patients with coronary artery disease and lesser platelet inhibition in respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubica, Aldona, Kozinski, Marek, Grzesk, Grzegorz, Fabiszak, Tomasz, Navarese, Eliano Pio, Goch, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181405/
https://www.ncbi.nlm.nih.gov/pubmed/21706290
http://dx.doi.org/10.1007/s11239-011-0611-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181405/
https://www.ncbi.nlm.nih.gov/pubmed/21706290
http://dx.doi.org/10.1007/s11239-011-0611-8

Ejemplares similares